Advertisement

Topics

Latest "Cellix Biosciences" News Stories

19:47 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "Cellix Biosciences" found in our extensive news archives from over 250 global news sources.

More Information about Cellix Biosciences on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cellix Biosciences for you to read. Along with our medical data and news we also list Cellix Biosciences Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cellix Biosciences Companies for you to search.

Showing "Cellix Biosciences" News Articles 1–25 of 1,300+

Relevant

Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S.

Cellix Biosciences Inc. (“Cellix Bio”), a development-stage pharmaceutical company, today announced confirmation from the U.S. Food and Drug Administration (FDA) that the 505(b)(2) regulatory pathway is appropriate for development of CLX-106 for treatment of relapsing-remitting multiple sclerosis (RRMS). CLX-106 is a novel molecular conjugate designed ...


Logic Biosciences Announces International Award for LBS-101 Program

Logic Biosciences, Inc., a development-stage pharmaceutical company, today announced that its lead product candidate, LBS-101, has been recognized with an Innovation in Oral Care Award from the International Association for Dental Research (IADR). LBS-101 is a long-acting topical formulation of a novel salt of bupivacaine, being developed for oral pain fro...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.


SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women for Biosciences (AWfB), launched on May 10, 2018 in Nairobi aims to address some of the challenges faced by women in biosciences. The event was part ...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...

Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigationor call to speak to our claim center toll-free at (844) 367-9658.   About the Lawsuit Solid Read more...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer

Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer Schlieren (Zurich), Switzerland, August 23, 2018 Kuros Biosciences AG (SIX: KURN) announced today the appointment of Pascal Long...

Pawar Law Group: Solid Biosciences Inc. Reminder: Important May 29, 2018 Lead Plaintiff Deadline in Class Action - SLDB

NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on...

#Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

VANCOUVER, British Columbia - August 1, 2018 (Investorideas.com Newswire) Sproutly Canada, Inc. (CSE:SPR) (FRA:38G) ("Sproutly" or the "Company") is pleased to announce that it has completed the acquisition of all of the issued and outstanding shares of Infusion Biosciences Canada Inc. ("Infusion Biosciences Canada") and SSM Partners Inc. ("SSM")

Sygnis acquires TGR BioSciences for €10.1mm

Sygnis AG brought in a complementary genomics/proteomics portfolio through the €10.1mm ($12mm) (net of cash) acquisition of...

Eli Lilly closes $1.6bn ARMO BioSciences acquisition

Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn. Lilly...Read More... The post Eli Lilly closes $1.6bn ARMO BioSciences acquisition appeared first on Pharmaceutical Technology.

Brii Biosciences options up to four Vir programs in China

Brii Biosciences launched and entered into an option agreement with Vir Biotechnology Inc.

Vortex Biosciences announces management changes

Bob Englert has been promoted from chief technology officer to CEO at Vortex Biosciences, replacing Gene Walther who has resi -More- 

Evelo Biosciences files for IPO

Evelo Biosciences Inc. (therapeutics for inflammatory diseases and cancer based on the gut-body network) filed for an initial...

BRIEF—Dyve Biosciences launches as dermal delivery technology company

Dyve Biosciences officially launched today as a new face in the biopharmaceutical space in Thousand Oaks,…

Reveal Biosciences, Science Exchange partner to apply AI to pathology

Reveal Biosciences is a San Diego-based company that’s leading the next generation of quantitative histopathology, combining the latest artificial intelligence (AI) techniques with high-quality histology, immunohistochemistry (IHC) and The post Reveal Biosciences, Science Exchange partner to apply AI to pathology appeared first on Compelo Medical Devices.

Pawar Law Group: Solid Biosciences Inc. Reminder: Pawar Law Reminds of Important May 29, 2018 Lead Plaintiff Deadline in Class Action- SLDB

NEW YORK, NY / ACCESSWIRE / May 25, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on o...

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - SLDB

NEW YORK, NY / ACCESSWIRE / April 7, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Solid Biosciences Inc. ("Solid Biosciences" or the "Company") (NASDAQ: SLDB) a...

Pawar Law Group: STOCK NOTICE: Pawar Reminds Solid Biosciences Inc. Investors of Important May 29, 2018 Lead Plaintiff Deadline in Class Action - SLDB

NEW YORK, NY / ACCESSWIRE / May 16, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on o...

Eli Lilly buys ARMO BioSciences for $1.6bn

Eli Lilly has announced that it will acquire immuno-oncology company ARMO BioSciences, including the company’s lead immuno-oncology product pegilodecakin, in...Read More... The post Eli Lilly buys ARMO BioSciences for $1.6bn appeared first on Pharmaceutical Technology.

Kuros Biosciences Ltd.: Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference

Schlieren (Zurich), Switzerland, June 19, 2018 Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference Kuros Biosciences will this week prese...

Roche licenses IPF candidate to Ark Biosciences

Roche’s Genentech Inc. licensed Ark Biosciences Inc. exclusive worldwide development and commercialization rights to its Ph...

Xenetic Biosciences Aktie: Was ist hier los?

Xenetic Biosciences arbeitet an innovativen neuen Medikamenten und Behandlungsmethoden, welche unter anderem im Kampf gegen Krebs helfen sollen. An der Börse wird das Unternehmen als Geheimtipp geh...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks